Balman Eswaran Bio Medicine And Materials Science Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 60.00 K
- Company Age 5 Months 10 Days
About Balman Eswaran Bio Medicine And Materials Science
Balman Eswaran Bio Medicine And Materials Science Private Limited (BEBMAMSPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 September 2024 ( five months 10 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Software Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 60.00 K , as per Ministry of Corporate Affairs (MCA) records.
Sambasivan Eswaran, Palaniswamy Manoharan, and Balakrishnan serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U72200TN2024PTC173397
- Company No.
173397
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Balman Eswaran Bio Medicine And Materials Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sambasivan Eswaran | Additional Director | 25-Sep-2024 | Current |
Palaniswamy Manoharan  | Director | 13-Sep-2024 | Current |
| Balakrishnan | Director | 13-Sep-2024 | Current |
Financial Performance of Balman Eswaran Bio Medicine And Materials Science.
Enhance accessibility to Balman Eswaran Bio Medicine And Materials Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Balman Eswaran Bio Medicine And Materials Science?
Unlock access to Balman Eswaran Bio Medicine And Materials Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Balman Eswaran Bio Medicine And Material S Science LlpPalaniswamy Manoharan and Balakrishnan are mutual person
- S B M Agency Llp
Palaniswamy Manoharan and Balakrishnan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Balman Eswaran Bio Medicine And Materials Science?
Unlock and access historical data on people associated with Balman Eswaran Bio Medicine And Materials Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Balman Eswaran Bio Medicine And Materials Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Balman Eswaran Bio Medicine And Materials Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.